PHARMACOGENOMIC DRUG INTERACTION
Clinical trials for PHARMACOGENOMIC DRUG INTERACTION explained in plain language.
Never miss a new study
Get alerted when new PHARMACOGENOMIC DRUG INTERACTION trials appear
Sign up with your email to follow new studies for PHARMACOGENOMIC DRUG INTERACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized dosing for kids with dystonia? new study investigates genetic factors
Knowledge-focused Recruiting nowThis study is testing how the drug trihexyphenidyl is processed in the bodies of 40 children aged 5-17 with dystonic cerebral palsy. Researchers want to see if a child's genetic makeup changes how the drug works, which could help create personalized dosing plans. Participants wil…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: PHASE1 • Sponsor: Children's Mercy Hospital Kansas City • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
ER genetic test aims to cut repeat trips to hospital
Knowledge-focused Recruiting nowThis study tests whether giving emergency room doctors genetic information about patients can help choose safer medications and reduce return visits. About 1,200 adults aged 40 and older who frequently visit the ER will be randomly assigned to receive genetic testing or usual car…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Gene test could prevent medication mishaps in hospitals
Knowledge-focused Recruiting nowThis study tests whether a quick genetic test from a cheek swab can help doctors choose safer, more effective medicines for hospital patients. About 2000 adults starting a new drug will be randomly assigned to get the test results immediately or after three months. The goal is to…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
DNA check could cut senior falls
Knowledge-focused Recruiting nowThis study explores whether using a person's DNA to guide medication choices can reduce harmful side effects in older adults who take five or more drugs. About 1,000 participants aged 65 and older who have had a fall will provide a cheek swab for DNA analysis. Half of the doctors…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: Florida Atlantic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Genetic test aims to stop drug side effects before they start
Knowledge-focused Recruiting nowThis study tests whether a genetic test can help doctors choose safer drugs and doses for 39 common medications. 66 adults getting a new prescription will receive the test, and researchers will track side effects like muscle aches, fainting, or mood changes for 48 weeks. The goal…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC